Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Harper

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: a Cancer Research Campaign trialR L Souhami, R Rudd, M C Ruiz de Elvira, et al.
Anti-Cancer Drugs|October 18, 2001
Multicenter phase II study of gemcitabine in previously untreated patients with advanced epithelial ovarian cancerC R Underhill, F X Parnis, M S Highley, et al.
British Journal of Cancer|June 1, 1996
A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trialL E James, N H Gower, R M Rudd, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Very high dose chemotherapy with autologous bone marrow rescue in adult patients with resistant relapsed lymphomaC C Anderson, A H Goldstone, R L Souhami, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Received dose-intensity: a randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancerD W Miles, O Fogarty, C M Ash, et al.
British Journal of Cancer|September 1, 1991
A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trialH M Earl, R M Rudd, S G Spiro, et al.
Thorax|September 13, 2008
Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancerS M Lee, L E James, W Qian, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancerR L Souhami, H T Hajichristou, D W Miles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2005
Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancerG Chong, A Bhatnagar, D Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer GroupR M Rudd, N H Gower, S G Spiro, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: a Cancer Research Campaign trialR L Souhami, R Rudd, M C Ruiz de Elvira, et al.
Anti-Cancer Drugs|October 18, 2001
Multicenter phase II study of gemcitabine in previously untreated patients with advanced epithelial ovarian cancerC R Underhill, F X Parnis, M S Highley, et al.
British Journal of Cancer|June 1, 1996
A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trialL E James, N H Gower, R M Rudd, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Very high dose chemotherapy with autologous bone marrow rescue in adult patients with resistant relapsed lymphomaC C Anderson, A H Goldstone, R L Souhami, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Received dose-intensity: a randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancerD W Miles, O Fogarty, C M Ash, et al.
British Journal of Cancer|September 1, 1991
A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trialH M Earl, R M Rudd, S G Spiro, et al.
Thorax|September 13, 2008
Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancerS M Lee, L E James, W Qian, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancerR L Souhami, H T Hajichristou, D W Miles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2005
Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancerG Chong, A Bhatnagar, D Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer GroupR M Rudd, N H Gower, S G Spiro, et al.
Pageof 13